Trial Details

COMPLETED
Basic Information
Clinical ID c1133
Identifier NCT05530122
Trial Title Prognosis in UC After First Biological
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions BIOLOGICAL: infliximab, adalimumab, golimumab, vedolizumab, ustekinumab
Participant Information
Sponsor Tampere University Hospital
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2009-01
Primary Completion Date 2020-01
Completion Date 2022-08-26